{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:25:46Z","timestamp":1759937146280,"version":"3.38.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1007\/bf03192294","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T13:20:01Z","timestamp":1288704001000},"page":"357-366","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol"],"prefix":"10.1007","volume":"23","author":[{"given":"H.","family":"Carsenti-Etesse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Farinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Durant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"De Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rouveix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dellamonica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03192294_CR1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/030006059001800105","volume":"18","author":"Y. Manach","year":"1990","unstructured":"Manach Y., Ditisheim A. (1990): Double-blind, placebo-controlled multicentre trial of the efficacy and tolerance of morniflumate suppositories in the treatment of tonsillitis in children. J. Int. Med. Res., 18, 30\u201336.","journal-title":"J. Int. Med. Res."},{"key":"BF03192294_CR2","first-page":"1119","volume":"46","author":"S. Bobin","year":"1989","unstructured":"Bobin S., Ditisheim A., Le Pajolec C., Harboun E., David N. (1989): A double-blind placebo-controlled trial of niflumic acid in the treatment of acute sinusitis. Curr. Ther. Res., 46, 1119\u20131128.","journal-title":"Curr. Ther. Res."},{"key":"BF03192294_CR3","first-page":"255","volume":"38","author":"C. Carbon","year":"1990","unstructured":"Carbon C. (1990): Antibiotiques et anti-inflammatoires. Pathol. Biol., 38, 255\u2013260.","journal-title":"Pathol. Biol."},{"key":"BF03192294_CR4","first-page":"11","volume":"13","author":"P. Dellamonica","year":"1993","unstructured":"Dellamonica P., Garraffo R., Carsenti-Etesse H., Bernard E., Mondain V. (1993): Pharmacokinetic and bacteriological study of cefadroxil-salicylate and josamycin-salicylate drug regimens. Int. J. Clin. Pharmacol. Res., 13, 11\u201319.","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"BF03192294_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0378-4347(00)82293-8","volume":"531","author":"F. Jehl","year":"1990","unstructured":"Jehl F., Gallion C., Monteil H. (1990): High performance liquid chromatography of antibiotics. J. Chromatogr., 531, 509\u2013548.","journal-title":"J. Chromatogr."},{"key":"BF03192294_CR6","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1128\/AAC.36.11.2462","volume":"36","author":"C. Duverne","year":"1992","unstructured":"Duverne C., Bouten A., Deslandes J.F. et al. (1992): Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system. Antimicrob. Agents Chemother., 36, 2462\u20132467.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF03192294_CR7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3565(25)22151-6","volume":"246","author":"V. Joly","year":"1988","unstructured":"Joly V., Pangon B., Brion N., Vallois J.M., Carbon C. (1988): Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac. J. Pharmacol. Exp. Ther., 246, 695\u2013700.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03192294_CR8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/infdis\/159.2.232","volume":"155","author":"D.O. Sordelli","year":"1989","unstructured":"Sordelli D.O., Cerquetti M.C., Fontan P.A., Meiss R.P. (1989): Piroxicam treatment protects mice from lethal pulmonary challenge withPseudomonas aeruginosa. J. Infect. Dis., 155, 232\u2013236.","journal-title":"J. Infect. Dis."},{"key":"BF03192294_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/155.5.985","volume":"155","author":"E. Tuomanen","year":"1987","unstructured":"Tuomanen E., Hengstler B., Rich R., Bray M.A., Zak O., Tomasz A. (1987): Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J. Infect. Dis., 155, 985\u2013989.","journal-title":"J. Infect. Dis."},{"key":"BF03192294_CR10","unstructured":"Khurana C.M., Deddish P.A. (1986): Treatment of osteomyelitis caused by oxacillin tolerantStaphylococcus aureus in rabbits. In: Proceedings of the 26th Interscience Conference of Antimicrobial Agents Chemotherapy, Abstract 544."},{"key":"BF03192294_CR11","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1073\/pnas.82.24.8771","volume":"82","author":"J.L. Rosner","year":"1985","unstructured":"Rosner J.L. (1985): Noninheritable resistance to chlor-amphenicol and the other antibiotics induced by salicylates and other chemotactic repellents inEscherichia coli K-12. Proc. Natl. Acad. Sci. USA, 82, 8771\u20138774.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03192294_CR12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF01967072","volume":"11","author":"P. Domenico","year":"1992","unstructured":"Domenico P., Leary R.O., Cunha B.A. (1992): Differential effects of bismuth and salicylate salts on the antibiotic susceptibility ofPseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis., 11, 170\u2013175.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"BF03192294_CR13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/AAC.34.5.786","volume":"34","author":"M. Aumercier","year":"1990","unstructured":"Aumercier M., Murray D.M., Rosner J.L. (1990): Potentiation of susceptibility to aminoglycosides by salicylate inEscherichia coli. Antimicrob. Agents Chemother., 34, 786\u2013791.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF03192294_CR14","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/jb.173.18.5631-5638.1991","volume":"173","author":"J.L. Rosner","year":"1991","unstructured":"Rosner J.L., Chai T.J., Foulds J. (1991): Regulation ofompF porin expression by salicylate inEscherichia coli. J. Bacteriol., 173, 5631\u20135638.","journal-title":"J. Bacteriol."},{"key":"BF03192294_CR15","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/AAC.36.10.2280","volume":"36","author":"J.L. Burns","year":"1992","unstructured":"Burns J.L., Clark K. (1992): Salicylate-inducible antibiotic resistance inPseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob. Agents Chemother., 36, 2280\u20132285.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF03192294_CR16","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.37.12.2743","volume":"37","author":"Y. Sumita","year":"1993","unstructured":"Sumita Y., Fukasawa M. (1993): Transient carbapenem resistance induced by salicylate inPseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis. Antimicrob. Agents Chemother., 37, 2743\u20132746.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03192294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03192294\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03192294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T13:28:44Z","timestamp":1740662924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03192294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["BF03192294"],"URL":"https:\/\/doi.org\/10.1007\/bf03192294","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}